Starting this January, California will begin selling affordable insulin pens directly to consumers. This groundbreaking initiative is the first by any state to bypass pharmaceutical companies’ control and address the high cost of diabetes treatment.
The American Customer Satisfaction Index read 76.1 in August 2026, the same score it held in 2015, so United States customer expectations have held flat for eleven years while complaints hit records and the variable that actually moved was tolerance.
Read More
TLDR: Regulated-industry marketers who build neuromarketing capabilities at pre-launch stage convert compliance...
Read More